Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

NextEra Energy’s Growth Strategy Will Begin to Pay Off

Renewable energy looks to be a hot sector for 2021, but that is only one reason that NEE stock is a compelling investment.

Nio Stock May Be a Great Buy If You Get Past the Question of Value

Nio has been one of the story stocks of 2020. But with most of the news looking baked into Nio stock is it a question of price over value?

You Can Love Virgin Galactic, But Let It Come Down to Earth

With things on Earth a mess, investors are eyeing space, specifically SPCE stock. But despite its appeal, the vision is still just a dream.

Microsoft Has Multiple Growth Paths

Microsoft stock thrived as remote work surged. Some see a threat coming from Salesforce, but Microsoft has many other paths of generating growth.

Fairly Valued Fastly Stock Isn’t a Buy-the-Dip Opportunity

The recent steep drop in FSLY stock has many bulls looking at a buy-on-the-dip opportunity. But the stock may actually be priced about right.

SolarEdge Needs Its Powerful USP to Charge Up Sales

Solar stocks are a popular way to invest in the renewable energy sector. But investors need to be careful with SEDG stock despite its compelling USP.

The Shock and Awe of Sorrento Therapeutics Is Long Gone

Sorrento Therapeutics was an early pandemic winner. But as the world closes in on multiple vaccines, SRNE stock looks to be too late.

5 Streaming Stocks to Buy for a Socially Distanced Holiday Season

2020 has been like the plot of a binge worthy show. Here are five streaming stocks that can help you profit no matter where the plot moves.

You Can Date Landcadia Holdings, But Hold Off On the Wedding

Rumors of a possible IPO regarding thetr company that is part of the LCA stock merger should make investors think twice about a long-term commitment.

SolarWindow Has An Intriguing Story And An Expensive Stock

Solar will be a big story in the next decade. SolarWindow may have a role to play. But without a product to sell, WNDW stock is pricey.